Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.39
Delayed Data
As of Feb 05
 -0.35 / -5.19%
Today’s Change
4.05
Today|||52-Week Range
11.26
-38.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues4.3M4.5M4.8M5.2M
 
 
 
 
 
Cost of Goods Sold879.5K1.0M1.0M1.2M
 
 
 
 
 
Depreciation And Amortization12.6K13.6K14.3K16.5K
 
 
 
 
 
 
Operating ExpensesGross Income3.4M3.4M3.8M4.0M
 
 
 
 
 
General Expenses19.7M24.3M31.1M23.5M
 
 
 
 
 
Research And Development14.2M18.2M24.2M16.4M
 
 
 
 
 
Total Operating Expenses20.6M25.4M32.1M24.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.3M-20.9M-27.3M-19.5M
 
 
 
 
 
Other Expenses3.2K18.5K25.6K27.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.3M-20.9M-27.2M-19.5M
 
 
 
 
 
Net Income-16.3M-20.9M-27.2M-19.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS156.1M163.4M172.8M177.2M
 
 
 
 
 
Shares To Calculate EPS Diluted156.1M163.4M172.8M177.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.13-$0.16-$0.11
 
 
 
 
 
EPS Diluted-$0.10-$0.13-$0.16-$0.11